Company Overview: Novo Nordisk, established in 1923 and based near Copenhagen, Denmark, is a leading global healthcare enterprise. With a mission to combat diabetes and various severe chronic ailments like obesity, rare blood disorders, and endocrine diseases, the company spearheads transformative initiatives. Through pioneering scientific breakthroughs, enhancing medication accessibility, and striving for disease prevention and eventual cures, Novo Nordisk endeavors to make a profound impact. Its extensive global footprint spans 80 offices, employing over 64,000 individuals, and its products reach consumers in 170 countries.